Increased insulin production and increased insulin sensitivity mean that we can more effectively move sugar out of the blood and into the cells, where it can be used for energy production and reduce our risk of developing diabetes
Medicare does not currently cover weight-loss drugs as a standard benefit
Access limitations or urgent medical need for metabolic control In some real-world cases, patients may face barriers to thyroid care (such as long wait times for endocrinology appointments) but have immediate access to a weight loss or diabetes program that includes GLP-1 medications
Wu HHM, Xie QQM, Zhao CCC et al (2019) Melatonin biosynthesis restored by CpG oligodeoxynucleotides attenuates allergic airway inflammation via regulating NLRP3 inflammasome
Patients received an initial dose of either 1 mg, 2 mg, or 4 mg of retatrutide and subsequent doses of either 1 mg, 4 mg, 8 mg, or 12 mg, or they received a placebo throughout the 48 weeks of the study